Nymox Pharmaceutical
NYMX
#10519
Rank
C$25.82 M
Marketcap
Country
C$0.28
Share price
0.00%
Change (1 day)
N/A
Change (1 year)

EPS for Nymox Pharmaceutical (NYMX)

EPS in 2023 (TTM): C-$0.08142

According to Nymox Pharmaceutical's latest financial reports the company's current EPS (TTM) is C-$0.08489. In 2022 the company made an earnings per share (EPS) of C-$0.11 an increase over its 2021 EPS that were of C-$0.21.

EPS history for Nymox Pharmaceutical from 1997 to 2023

Annual EPS

Year EPS Change
2023 (TTM)C-$0.08142-28.07%
2022C-$0.11-46.67%
2021C-$0.21-11.76%
2020C-$0.24-15%
2019C-$0.285.26%
2018C-$0.27-26.92%
2017C-$0.37-7.14%
2016C-$0.40-40.43%
2015C-$0.67291.67%
2014C-$0.17-7.69%
2013C-$0.18-43.48%
2012C-$0.33-25.81%
2011C-$0.4455%
2010C-$0.2825%
2009C-$0.230.08%
2008C-$0.23-11.12%
2007C-$0.25-0.16%
2006C-$0.2528.59%
2005C-$0.20-12.49%
2004C-$0.23-16.05%
2003C-$0.2719.07%
2002C-$0.2314.45%
2001C-$0.20-22.16%
2000C-$0.255.64%
1999C-$0.24-34.59%
1998C-$0.37-3.6%
1997C-$0.38

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
C$12.36-14,660.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
C$1.85-2,283.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
C$5.11-6,114.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
C$39.94-47,142.17%๐Ÿ‡บ๐Ÿ‡ธ USA
Quest Diagnostics
DGX
C$12.97-15,383.33%๐Ÿ‡บ๐Ÿ‡ธ USA